Abstract
Background
Viscosupplementation, with hyaluronan derivates injected into the intra-space of osteoarthritic joints, is now widely used for the treatment of knee osteoarthritis. This study evaluates the results in terms of pain and disability of intra-articular injections of hyaluronan derivates into the ankle joint in patients suffering from grade II primary or secondary osteoarthritis of the ankle.
Methods
Twenty-one patients with a painful ankle and radiographic evidence of grade II osteoarthritis had three weekly intra-articular injections of 2 ml of hylan G-F 20 (10 mg/ml) into the ankle joint. The primary clinical outcome measurement was the ankle osteoarthritis score (AOS) at the baseline, and at 6, 12 and 18 months.
Results
Significant improvement of the AOS from baseline was seen after 6 months (p=0.0001). This improvement was maintained over time with no further changes at 12- and 18-month follow-ups. Regarding pain, the AOS improved over time from the baseline to the 18-month follow up and became statistically significant at the 12- and 18-month follow-ups (p<0.05).
Similar content being viewed by others
References
Creamer P, Hochberg MC (1997) Osteoarthritis. Lancet 350:503–508
Felson DT, Lawrence RC, Dieppe PA et al (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646
Buckwalter JA, Mankin HJ (1998) Articular cartilage: degeneration and osteoarthritis, repair, regeneration and traspantation. Instr Course Lect 47:487–504
Abramson SB (2003) The role of NSAIDs in the treatment of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, pp 251–258
Juni P, Nartey L, Reichenbach S et al (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364:2021–2029
Rashad S, Revell P, Hemingway A et al (1989) Effect of nonsteroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 2:519–522
Sevstik J, Lemperg R (1969) Local bone destruction after intraarticular injection of corticosteroids. Nord Med 81:949–951
Vitanzo PC, Sennett BJ (2006) Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop 35:421–428
Waddell DD, Bricker DC (2007) Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 13:113–121
Stitik TP, Blacksin MF, Stiskal DM et al (2007) Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain. Arch Phys Med Rehabil 88:135–141
Salk R, Chang T, D’Costa W et al (2005) Viscosupplementation (hyaluronans) in the treatment of ankle osteoarthritis. Clin Podiatr Med Surg 22:585–597
Salk R, Chang T, D’Costa W et al (2006) Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88:295–302
Balazs EA, Denlinger JL (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 39:3–9
Wang CT, Lin YT, Chiang BL et al (2006) High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblastlike synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 14:1237–1247
Kellgren JH, Lawrence JS (1963) Atlas of standard radiographs: the epidemiology of chronic rheumatism, Vol. 2. Blackwell Scientific Publications, Oxford, UK
Chow S, Brandser E (1998) Diagnostic and therapeutic foot and ankle injections. Semin Musculoskelet Radiol 2:421–432
Domsic RT, Saltzman CL (1998) Ankle osteoarthritis scale. Foot Ankle Int 19:466–471
Sun SF, Chou YJ, Hsu CW et al (2006) Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis Cartilage 14:867–874
Carrabba M, Paresce E, Angelini M et al (1995) The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15:25–31
Kotz R, Kolarz G (1999) Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 28[Suppl 11]:5–7
Scale D, Wobig M, Wolpert W (1994) Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 55:220–232
Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 32:10–37
Jackson DW, Simon M (2006) Intra-articular distribution and residence time of Hylan A and B: a study in the goat knee. Osetoarthritis Cartilage 14:1248–1257
Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA (2001) Efficacy of intra-articular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res 390:173–181
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luciani, D., Cadossi, M., Tesei, F. et al. Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months’ follow-up. Chir Organi Mov 92, 155–160 (2008). https://doi.org/10.1007/s12306-008-0066-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12306-008-0066-z